(RTTNews) - Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced Friday the approval of a generic version of Forteo in the United States. Forteo had ...
Please provide your email address to receive an email when new articles are posted on . Teva Pharmaceuticals announced FDA approval of a generic version of Forteo in ...
PARSIPPANY, N.J. & TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the approval of a ...
SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Pfenex (NYSE American:PFNX) and Alvogen today announced entering into an agreement granting Alvogen exclusive rights to commercialize Pfenex’s lead drug ...
Pfenex has received the Food and Drug Administration’s blessing for PF708. The product uses Forteo (teriparatide injection) as a reference drug, and like Forteo is indicated for the treatment of ...
INDIANAPOLIS, May 29, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data showing that FORTEO significantly increased lumbar spine volumetric bone mineral density (vBMD) ...
SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that its commercialization partner, Alvogen, has launched Teriparatide Injection in the United States.
Pfenex Inc. and China NT Pharma Group Company Limited (NT Pharma) announced an agreement under which Pfenex granted NT Pharma non-exclusive development and exclusive commercialization rights to PF708, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results